Apr 11, 2007 by Brian LawlerMedImmune Brings Home the BaconDrugmaker MedImmune announces preliminary first-quarter financial results.
Apr 11, 2007 by Brian LawlerGet Rich With These GuysCertain leaders in the health-care sector have a way of being successful with nearly everything they touch.
Apr 10, 2007 by Brian LawlerBarr Issues a ChallengeBarr challenges the patents on one of Sanofi's top drugs.
Apr 5, 2007 by Brian LawlerImClone Steps to the FrontImClone announces a successful clinical trial for the cancer drug Erbitux.
Apr 4, 2007 by Brian LawlerGlaxoSmithKline Gets Ready for the Vaccine WarsGlaxoSmithKline submits a marketing application to the FDA for its HPV vaccine.
Apr 4, 2007 by Brian LawlerNovartis Gets NickedNovartis pulls one of its top-selling drugs from the market.
Apr 4, 2007 by Brian LawlerCompanies That Pay Out ... and DropAn explanation of why a stock price falls after a large one-time dividend payout.
Apr 3, 2007 by Brian LawlerDendreon's Positive Panel SurpriseShares of Dendreon jump after an FDA advisory panel finds in favor of its lead drug.
Apr 3, 2007 by Brian LawlerMerck Gets the ComboMerck gets marketing approval for a diabetes combination drug.
Apr 2, 2007 by Brian LawlerPain Therapeutics Pares SharesThe small drugmaker announces a share buyback.
Apr 2, 2007 by Brian LawlerAmerican Oriental's Political TwistsAmerican Oriental announces new pricing rules for its top product.
Apr 2, 2007 by Brian LawlerProgenics Submits for Its FutureProgenics submits a New Drug Application for its lead compound.
Apr 2, 2007 by Brian LawlerFDA Keeps Cephalon WaitingThe FDA issues Cephalon an approvable letter for one of its drugs.
Mar 29, 2007 by Brian LawlerGenentech Going ForwardGenentech gives guidance for first-quarter sales numbers.
Mar 28, 2007 by Brian LawlerAtheroGenics Splices the DataAtheroGenics reveals more details about a phase 3 study for its lead compound.
Mar 23, 2007 by Brian LawlerMylan TKOs PfizerMylan launches a generic version of Pfizer's second-best selling drug.
